Neurotoxicity of MDMA (ecstasy): beyond metabolism

被引：13

作者：

Sprague, JE ^{[1
]}

Nichols, DE

机构：

[1] Virginia Polytech Inst & State Univ, Virginia Coll Osteopath Med, Blacksburg, VA 24060 USA

[2] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24060 USA

[3] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 2005年 / 26卷 / 02期

关键词：

D O I：

10.1016/j.tips.2004.12.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：59 / 60

页数：2

共 19 条

[1] Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion [J].

Chu, T ;

Kumagai, Y ;

DiStefano, EW ;

Cho, AK .

BIOCHEMICAL PHARMACOLOGY, 1996, 51 (06) :789-796

[2] In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine [J].

Colado, MI ;

OShea, E ;

Granados, R ;

Murray, TK ;

Green, AR .

BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (05) :889-900

[3] THE HYPERTHERMIC AND NEUROTOXIC EFFECTS OF ECSTASY (MDMA) AND 3,4-METHYLENEDIOXYAMPHETAMINE (MDA) IN THE DARK-AGOUTI (DA) RAT, A MODEL OF THE CYP2D6 POOR METABOLIZER PHENOTYPE [J].

COLADO, MI ;

WILLIAMS, JL ;

GREEN, AR .

BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) :1281-1289

[4] The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats [J].

Darvesh, AS ;

Gudelsky, GA .

NEUROTOXICOLOGY AND TERATOLOGY, 2004, 26 (04) :571-577

[5] Neurotoxicity of MDMA (ecstasy):: the limitations of scaling from animals to humans [J].

de la Torre, R ;

Farré, M .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (10) :505-508

[6] 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected nenrotoxic dose [J].

Esteban, B ;

O'Shea, E ;

Camarero, J ;

Sanchez, V ;

Green, AR ;

Colado, MI .

PSYCHOPHARMACOLOGY, 2001, 154 (03) :251-260

[7] An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA [J].

Falk, EM ;

Cook, VJ ;

Nichols, DE ;

Sprague, JE .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 72 (03) :617-622

[8] The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") [J].

Green, AR ;

Mechan, AO ;

Elliott, JM ;

O'Shea, E ;

Colado, MI .

PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :463-508

[9] REDUCTION IN BRAIN-SEROTONIN MARKERS BY ALPHA-ETHYLTRYPTAMINE (MONASE) [J].

HUANG, XM ;

JOHNSON, MP ;

NICHOLS, DE .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 200 (01) :187-190

[10] Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells [J].

Jones, DC ;

Lau, SS ;

Monks, TJ .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :298-306

← 1 2 →